10.08.2013 Views

Download the supplement (208 p.) - KCE

Download the supplement (208 p.) - KCE

Download the supplement (208 p.) - KCE

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>KCE</strong> reports vol. 40 APPENDICES Physio<strong>the</strong>rapy 51<br />

The current fit of existing tests for global ICF dimensions is often incomplete for varying pathologies.<br />

This could regard both <strong>the</strong> absence of an exhaustive list of item tests or of overall global scoring<br />

measures. Questions regarding <strong>the</strong> link between scoring outcomes and reimbursement terms remain.<br />

The gain in taxonomic simplicity brought on by globalizing dimension scores would be partially offset<br />

by adding an initial pathology-based classification. As shown in our prospective research <strong>the</strong> ten most<br />

frequent pathologies only accounted for 43,3% of attributed treatment sessions. As some of <strong>the</strong>se<br />

defined pathologies should be fur<strong>the</strong>r subdivided for obvious reasons (e.g. presence of orthopaedic<br />

implants into anatomic categories: hip, knee, etc.) it should be clear that any top-down pathologybased<br />

classification would require a manifold of base categories if some degree of overall real life<br />

exhaustiveness is aspired to.<br />

The general concern for proper coding practices and related scientific relevance of ICF tools also<br />

prevails in a partial coding system.<br />

Following <strong>the</strong> exposed arguments, our conclusion reads that <strong>the</strong> disadvantages full ICF codification as a<br />

reimbursement framework entails, also apply to schemes resorting to partial ICF coding: unmanageable<br />

organisational complexity, scientific uncertainty (at present) and deterioration of ICF tools as clinical<br />

standards.<br />

3. CONCLUSION<br />

As stated by our research most analysed fee-for-service schemes favour an approach based on a rudimentary<br />

classification of pathologies into broad reimbursement categories that correspond to a set number of entitled<br />

treatment episodes. Exceptional patient cases warrant complementary treatment on an ad hoc basis through<br />

additional administrative measures (follow-up prescriptions, etc.). Fur<strong>the</strong>r observed developments regard care<br />

capitation and product bundling. These measures aim to simplify billing procedures and make third-party<br />

expenditures more manageable.<br />

Consequently, observed reimbursement schemes appear to be driven by an impetus toward organisational<br />

simplicity ra<strong>the</strong>r than attested clinical effectiveness. As our discussion on ICF coding aimed to demonstrate,<br />

this approach is justified from a third-party payer perspective. Even more so, applying ICF as a reimbursement<br />

reference could be detrimental to its intrinsic scientific relevance. Therefore, it should be clear that <strong>the</strong><br />

significance of ICF as a policy tool must be restricted to its use as a complementary and strictly scientific<br />

means, in time perhaps helping to fill a crucial void in assuring <strong>the</strong> quality of physio<strong>the</strong>rapy care.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!